Anebulo Pharmaceuticals Inc
(ANEB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,202 | -6,852 | -5,198 | -2,481 | -11,732 |
| Depreciation Amortization | 151 | 92 | 32 | N/A | N/A |
| Accounts payable and accrued liabilities | -378 | -150 | -216 | 31 | 154 |
| Other Working Capital | -799 | 141 | 196 | -457 | 1,165 |
| Other Operating Activity | 1,137 | 731 | 646 | 179 | 731 |
| Operating Cash Flow | $-8,091 | $-6,038 | $-4,541 | $-2,727 | $-9,683 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 6,699 |
| Other Financing Activity | -62 | -62 | -62 | 0 | -317 |
| Financing Cash Flow | $-62 | $-62 | $-62 | $N/A | $6,382 |
| Beginning Cash Position | 11,247 | 11,247 | 11,247 | 11,247 | 14,549 |
| End Cash Position | 3,094 | 5,147 | 6,645 | 8,521 | 11,247 |
| Net Cash Flow | $-8,153 | $-6,100 | $-4,603 | $-2,727 | $-3,301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,091 | -6,038 | -4,541 | -2,727 | -9,683 |
| Free Cash Flow | -8,091 | -6,038 | -4,541 | -2,727 | -9,683 |